Anthony Johnson
Dermatology · Bountiful, UTNPI 1396230116
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $814 of the $978 with a category attached, or 83.2%. It is spread thinly across 12 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $409, 6.0 times the $68 reported in 2021. That places this record below the midpoint for dermatology clinicians in UT, where the typical reported total is $1,056.
Across 41 payments — averaging $23.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$214
- Johnson & Johnson$212
- AbbVie$174
- Lilly USA, LLC$106
- LEO Pharma Inc.$102
- VYNE Pharmaceuticals Inc.$53
- plus $116 from 6 others
What the payments were for
- Food & beverage$81483%
- Education$16417%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 9 | $214 |
| Johnson & Johnson(2 entities) | 5 | $212 |
| AbbVie | 9 | $174 |
| Lilly USA, LLC | 6 | $106 |
| LEO Pharma Inc. | 4 | $102 |
| VYNE Pharmaceuticals Inc. | 1 | $53 |
| Arcutis Biotherapeutics, Inc. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Botanix SB Inc | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Incyte Corporation | 1 | $13 |
| Organon | 1 | $2 |
How this compares
$978 in reported general payments places this provider in the 45th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clindamycin Phosphate | 15 | $834 |
| Doxycycline Monohydrate | 28 | $563 |
| Ketoconazole | 36 | $561 |
| Triamcinolone Acetonide | 47 | $547 |
| Clobetasol Propionate | 12 | $350 |
| Mupirocin | 21 | $191 |
| Minoxidil | 18 | $177 |
| Hydrocortisone | 16 | $87 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Bountiful
- Jason HadleyBountiful$294K
- Brian WilliamsMidvale$876K
- Travis JamesProvidence$437K
- Doug Lass ForshaWest Jordan$213K
- Gerald KruegerSalt Lake City$156K
- Jamie RhoadsMurray$105K
- Kristina DuffinSalt Lake City$89K
- Mark TaylorSalt Lake City$58K
- Lori RamirezKaysville$38K
- Sancy LeachmanMurray$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.